{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:50:45Z","timestamp":1790707845786,"version":"4.1.0"},"reference-count":33,"publisher":"American Society for Microbiology","issue":"12","license":[{"start":{"date-parts":[[1999,12,1]],"date-time":"1999-12-01T00:00:00Z","timestamp":944006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[1999,12]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Extended-spectrum \u03b2-lactamases (ESBLs) are enzymes produced in some gram-negative bacilli that mediate resistance to extended-spectrum cephalosporins and aztreonam. They are most common in\n            <jats:italic>Klebsiella<\/jats:italic>\n            spp. and\n            <jats:italic>Escherichia coli<\/jats:italic>\n            but are present in a variety of\n            <jats:italic>Enterobacteriaceae<\/jats:italic>\n            . Resistance mediated by these enzymes can be difficult to detect depending on the antimicrobial agents tested. AmpC \u03b2-lactamases are related to the chromosomal enzymes of\n            <jats:italic>Enterobacter<\/jats:italic>\n            and\n            <jats:italic>Citrobacter<\/jats:italic>\n            spp. and also mediate resistance to extended-spectrum cephalosporins and aztreonam in addition to cephamycins, such as cefoxitin. Unlike ESBLs, however, AmpC \u03b2-lactamases are not inhibited by clavulanic acid or other similar compounds. To assess the abilities of various antimicrobial susceptibility testing methods to detect ESBLs, we sent three ESBL-producing organisms, one AmpC-producing organism, and a control strain that was susceptible to extended-spectrum cephalosporins to 38 laboratories in Connecticut for testing. Eight (21.0%) of 38 labs failed to detect extended-spectrum cephalosporin or aztreonam resistance in any of the ESBL- or AmpC-producing isolates. Errors were encountered with both automated and disk diffusion methods. Conversely, seven (18.4%) labs categorized at least some of the four resistant isolates as potential ESBL producers and reported the results with the extended-spectrum cephalosporins and aztreonam as resistant as suggested by current National Committee for Clinical Laboratory Standards (NCCLS) guidelines. The percentage of laboratories that failed to detect resistance in the ESBL or AmpC isolates ranged from 23.7 to 31.6% depending on the type of enzyme present in the test organism. This survey suggests that many laboratories have difficulty detecting resistance in ESBL and AmpC-producing organisms and may be unaware of the NCCLS guidelines on modifying susceptibility testing reports for ESBL-producing strains.\n          <\/jats:p>","DOI":"10.1128\/jcm.37.12.4065-4070.1999","type":"journal-article","created":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T17:41:59Z","timestamp":1577814119000},"page":"4065-4070","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":79,"title":["Detection and Reporting of Organisms Producing Extended-Spectrum \u03b2-Lactamases: Survey of Laboratories in Connecticut"],"prefix":"10.1128","volume":"37","author":[{"given":"Fred C.","family":"Tenover","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Hospital Infections Program, Centers for Disease Control and Prevention, Atlanta, Georgia 303331;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Jasmine","family":"Mohammed","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Hospital Infections Program, Centers for Disease Control and Prevention, Atlanta, Georgia 303331;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy S.","family":"Gorton","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->University of Connecticut, Department of Pathobiology, Storrs, Connecticut 062692; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zygmunt F.","family":"Dembek","sequence":"additional","affiliation":[{"name":"<!--label omitted: 3-->Epidemiology Program, Connecticut Department of Public Health, Hartford, Connecticut 06134-03083"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01967377"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.6.1211"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/24.1.82"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.1999.tb00096.x"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.34.8.1880-1884.1996"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.35.10.2593-2597.1997"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.35.8.2061-2067.1997"},{"key":"e_1_3_2_9_2","unstructured":"Farmer\nJ. J.\nIII. Enterobacteriaceae : introduction and identification\nManual of clinical microbiology\n6th ed.\nMurray\nP. R.\nBaron\nE. J.\nPfaller\nM. A.\nTenover\nF. C.\nYolken\nR. H.\n1995\n438\n449\nAmerican Society for Microbiology\nWashington D.C"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.34.2.358-363.1996"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.35.9.1697"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/10.4.867"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.32.3.691-696.1994"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.8.4.557"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1099\/00221287-88-1-169"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/24.Supplement_1.S19"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.36.9.2575-2579.1998"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.2307\/30141189"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.2.458"},{"key":"e_1_3_2_20_2","unstructured":"National Committee for Clinical Laboratory Standards\nPerformance standards for antimicrobial disk susceptibility tests 6th ed. vol. 17 no. 1. Approved standard M2-A6.\n1997\nNational Committee for Clinical Laboratory Standards\nWayne Pa"},{"key":"e_1_3_2_21_2","unstructured":"National Committee for Clinical Laboratory Standards\nMethods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically 4th ed. vol. 17 no. 2. Approved standard M7-A4.\n1997\nNational Committee for Clinical Laboratory Standards\nWayne Pa"},{"key":"e_1_3_2_22_2","unstructured":"National Committee for Clinical Laboratory Standards\nPerformance standards for antimicrobial susceptibility testing. Eighth informational supplement M100-S8.\n1998\nNational Committee for Clinical Laboratory Standards\nWayne Pa"},{"key":"e_1_3_2_23_2","unstructured":"National Committee for Clinical Laboratory Standards\nPerformance standards for antimicrobial susceptibility testing. Ninth informational supplement M100-S9.\n1999\nNational Committee for Clinical Laboratory Standards\nWayne Pa"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.37.5.962"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0732-8893(97)00064-3"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1086\/514643"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.34.3.564-568.1996"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.14.1233"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.3.647"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.34.11.2193"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.34.12.2997-3001.1996"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.36.9.1877"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.35.9.2191-2197.1997"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.6.517"}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.37.12.4065-4070.1999","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.37.12.4065-4070.1999","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T23:57:14Z","timestamp":1646438234000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JCM.37.12.4065-4070.1999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,12]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[1999,12]]}},"alternative-id":["10.1128\/JCM.37.12.4065-4070.1999"],"URL":"https:\/\/doi.org\/10.1128\/jcm.37.12.4065-4070.1999","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,12]]},"assertion":[{"value":"1999-06-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1999-09-01","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"1999-12-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}